Search
You have searched for "Hepatitis C drug"
Showing 1-10 of 42
Pharmaniaga returns to the black in fourth quarter
PETALING JAYA: Pharmaniaga Bhd is back in the black, posting a net profit of RM85.5mil in the fourth quarter ended Dec 31, 2021, compared to losses of RM6.33mil a year earlier.
Malaysia marks journey as Hepatitis C treatment hub of Asia
KUALA LUMPUR: Malaysia has been featured as the Hepatitis C Treatment Hub of Asia at Expo 2020 Dubai during the opening ceremony of Malaysia Healthcare Excellence week at the Malaysia Pavilion, according to the Malaysia Healthcare Travel Council (MHTC).
Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India
BENGALURU (Reuters) - India's Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial, the drugmaker said on Monday.
More access to Hep C treatment
KUALA LUMPUR: Those at risk of getting Hepatitis C can now get screened, tested and treated if needed, at any Health Ministry clinic nationwide, said the ministry.
Stage set for access to Hepatitis C treatment
KUALA LUMPUR: Twenty months after sofosbuvir, the generic Hepatitis C drug was brought into Malaysia through compulsory licensing, only some 4,500 patients have been treated, says the Health Ministry.
Free Hepatitis C testing nationwide
PETALING JAYA: Free Hepatitis C screenings will be offered in over 100 locations nationwide in the biggest national screening campaign ever.
Pricey problems with medicine
A global ‘war’ on exorbitant drug prices looks set to be sparked at a meeting in Geneva tomorrow.
Ministry calls on WHO to look into drug pricing
KUALA LUMPUR: Amidst pressure against Malaysia for using compulsory licensing (CL) to gain access to generic versions of a Hepatitis C drug, the Health Ministry has urged the World Health Organisation (WHO) to look into the pricing system of medicine by big pharmaceutical companies.
As medical costs mount, Japan to weigh cost-effectiveness in setting drug prices
TOKYO (Reuters) - Japanese doctor Yasushi Goto remembers prescribing the cancer drug Opdivo to an octogenarian and wondering whether taxpayers might object to helping fund treatment, which at the time cost hundreds of thousands of dollars, for patients in their twilight years.
MSF gives thumbs up for Hep C efforts
KUALA LUMPUR: Malaysia has received a boost from an international medical humanitarian organisation for its effort to gain access to generic versions of a Hepatitis C drug.
